The effects of robot-assisted gait training in progressive multiple sclerosis: A randomized controlled trial
| Autor: | Bruno Rossi, Carmelo Chisari, Carlotta Martinuzzi, Sofia Straudi, Claudia Pavarelli, Nino Basaglia, Chiara Fanciullacci |
|---|---|
| Jazyk: | angličtina |
| Rok vydání: | 2016 |
| Předmět: |
Adult
Male 030506 rehabilitation medicine.medical_specialty QoL Multiple Sclerosis Timed Up and Go test Gait Multiple sclerosis Rehabilitation Robot-assisted gait training Exercise Therapy Female Gait Disorders Neurologic Humans Middle Aged Multiple Sclerosis Chronic Progressive Quality of Life Single-Blind Method Exoskeleton Device Robotics Neurology Neurology (clinical) law.invention NO 03 medical and health sciences gait multiple sclerosis rehabilitation 0302 clinical medicine Physical medicine and rehabilitation Quality of life Randomized controlled trial Gait training law Neurologic Medicine Gait Disorders Balance (ability) Expanded Disability Status Scale business.industry Chronic Progressive Berg Balance Scale Physical therapy 0305 other medical science business 030217 neurology & neurosurgery |
| Popis: | Background: Gait and mobility impairments are common in progressive multiple sclerosis (MS), leading to reduced quality of life (QoL). Objective: In this randomized controlled study, we tested the effects of robot-assisted gait training (RAGT) and compared it to conventional physiotherapy, measuring walking ability, depression, fatigue, and QoL in patients with progressive MS and severe gait disability. Methods: Fifty-two participants (Expanded Disability Status Scale score 6–7) completed the study protocol. They received two sessions/week over 6 weeks of RAGT or conventional walking therapy. Outcome measures were Six-Minute Walk Test, Ten-Meter Walk Test, Timed Up and Go Test, Berg Balance Scale, Fatigue Severity Scale, Patient Health Questionnaire, and Short Form 36. They were performed pre-treatment, post-treatment, and at 3 months. Results: Walking endurance ( p Conclusion: RAGT is a treatment option in progressive MS patients with severe gait impairments to induce short-lasting effects on mobility and QoL. |
| Databáze: | OpenAIRE |
| Externí odkaz: |
|